SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

HAUSLER, Harry Peter et al. Costs of measures to control tuberculosis/HIV in public primary care facilities in Cape Town, South Africa. Bull World Health Organ [online]. 2006, vol.84, n.7, pp. 528-536. ISSN 0042-9686.  http://dx.doi.org/10.1590/S0042-96862006000700014.

    1. Department of Health. National HIV and syphilis antenatal sero-prevalence survey in South Africa, 2004. Pretoria: Department of Health; 2005. [ Links ]

    2. Joint United Nations Programme on HIV/AIDS (UNAIDS). 2004 report on the global AIDS epidemic: 4th global report. Geneva: UNAIDS/World Health Organization; 2004. [ Links ]

    3. Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. New Engl J Med 1989;320:545-50. [ Links ]

    4. Daley CL, Small PM, Schecter GF, Schoolnik GK, McAdam RA, Jacobs WR Jr, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. New Engl J Med 1992;326:231-5. [ Links ]

    5. Bleed D, Dye C, Raviglione M. Dynamics and control of the global tuberculosis epidemic. Curr Opin Pulm Med 2000;6:174-9. [ Links ]

    6. World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO Report 2005. Geneva: WHO; 2005. WHO document WHO/HTM/TB/2005.349. [ Links ]

    7. Kustner HGV. The trend of tuberculosis through the eyes of cohorts. Epidemiol Comments 1992;19:184-97. [ Links ]

    8. World Health Organization. Report of the 2005 annual TB review of the National Tuberculosis Control Programme of South Africa 2-12 October 2005. Geneva: World Health Organization and South African Department of Health; 2005. [ Links ]

    9. World Health Organization. Joint review of the South African Tuberculosis Control Programme. Geneva: South African Department of Health and WHO; 1996. [ Links ]

    10. Department of Health. National STD/HIV/AIDS Review. Pretoria: Department of Health; 1997. [ Links ]

    11. Hausler H. Lessons learned in South African TB/HIV pilot districts. S Afr Resp J 2002;8:17-22. [ Links ]

    12. World Health Organization. Report of a "Lessons Learnt" Workshop on the Six ProTEST Pilot Projects in Malawi, South Africa and Zambia. Geneva: WHO; 2004. [ Links ]

    13. Sweat M, Gregorich S, Sangiwa G, Furlonge C, Balmer D, Kamenga C, et al. Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania. Lancet 2000;356:113-21. [ Links ]

    14. Wilkinson D, Wilkinson M, Lombard C, Martin D, Smith A, Floyd K, et al. On-site testing in resource-poor settings: is one rapid test enough? AIDS 1997;11:377-81. [ Links ]

    15. Bell JC, Rose DN, Sacks HS. Tuberculosis preventive therapy for HIV-infected people in sub-Saharan Africa is cost-effective. AIDS 1999;13:1549-56. [ Links ]

    16. Masobe P, Lee T, Price M. Isoniazid prophylactic therapy for tuberculosis in HIV-seropositive patients — a least-cost analysis. S Afr Med J 1995;85:75-81. [ Links ]

    17. Heymann SJ. Modelling the efficacy of prophylactic and curative therapies for preventing the spread of tuberculosis in Africa. Trans R Soc Trop Med Hyg 1993;87:406-11. [ Links ]

    18. Foster S, Godfrey-Faussett P, Porter J. Modelling the economic benefits of tuberculosis preventive therapy for people with HIV: the example of Zambia. AIDS 1997;11:919-25. [ Links ]

    19. Aisu T, Raviglione M, van Praag E, Eriki P, Narain JP, Barugahare L, et al. Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre. AIDS 1995;9:267-73. [ Links ]

    20. Bachmann MO. Effectiveness and cost effectiveness of early and late prevention of HIV/AIDS progression with antiretrovirals or antibiotics in Southern African adults. AIDS Care 2006;18:109-20. [ Links ]

    21. Department of Health, Provincial Administration of the Western Cape. The provincial and district HIV antenatal survey Western Cape 2002. Cape Town: Department of Health; 2002. [ Links ]

    22. Kumaranayake L, Pepperall J, Goodman H, Mills A. Costing guidelines for HIV/AIDS prevention strategies. UNAIDS Best Practice Collection — Key Materials. Geneva: UNAIDS; 2000. [ Links ]

    23. Du Preez M. The discount rate for public sector conservation projects in South Africa. Afr Dev Rev 2004;16:456-71. [ Links ]

    24. Kumaranayake L. The real and the nominal? Making inflationary adjustments to cost and other economic data. Health Policy Plan 2000;15:230-4. [ Links ]

    25. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003;163:1009-21. [ Links ]

    26. Wood R, Maartens G, Lombard CJ. Risk factors for developing tuberculosis in HIV-1 infected adults from communities with a low or very high incidence of tuberculosis. J Acquir Immune Defic Syndr 2000;23:75-80. [ Links ]

    27. Dye CS, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999;282:677-86. [ Links ]

    28. Vynnycky E, Fine PE. The natural history of tuberculosis: the implications of age-dependant risks of disease and the role of reinfection. Epidemiol Infect 1997;119:183-201. [ Links ]

    29. Borgdorff MW, Fine PE, Leung CC, Tam CM, Vynnycky E. Slow decline of tuberculosis notifications in Hong Kong, China: evidence for a high risk of developing reactivational disease? TSRU Prog Rep 2003;123-40. [ Links ]

    30. Sonnenberg P, Glynn JR, Fielding K, Murray J, Godfrey-Faussett P, Shearer S. How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. J Infect Dis 2005;191:150-8. [ Links ]

    31. Wilkinson D, Squire SB, Garner P. Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomized placebo controlled trials. BMJ 1998;317:625-9. [ Links ]

    32. Styblo K. Epidemiology of tuberculosis. The Hague: VEB Gustav Fischer Verlag Jena; 1984. [ Links ]

    33. Corbett EL, Charalambous S, Moloi VM, Fielding K, Grant AD, Dye C, et al. Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners. Am J Respir Crit Care Med 2004;170:673-9. [ Links ]

    34. City of Cape Town. City of Cape Town/Metropole region TB control programme progress report 1997–2002. Cape Town: City of Cape Town; 2003. [ Links ]

    35. Bucher HC, Griffith LE, Guyatt GH, Sudre P, Naef M, Sendi P, et al. Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials. AIDS 1999;13:501-7. [ Links ]

    36. World Health Organization. Preventive therapy against tuberculosis in people living with HIV. Wkly Epidemiol Rec 1999;74:385-400. [ Links ]

    37. Gravelle H, Smith D. Discounting for health effects in cost-benefit and cost-effectiveness analysis. Health Econ 2001;10:587-99. [ Links ]

    38. van Hout BA. Discounting costs and effects: a reconsideration. Health Econ 1998;7:581-94. [ Links ]

    39. Voluntary HIV-1 Counseling and Testing Efficacy Study Group. Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: a randomised trial. Lancet 2000;356:103-12. [ Links ]

    40. Gilson L, Mkanje R, Grosskurth H, Mosha F, Picard J, Gavyole A, et al. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania. Lancet 1997;350:1805-9. [ Links ]

    41. Marseille E, Kahn JG, Mmiro F, Guay L, Musoke P, Fowler MG, et al. Cost effectiveness of single dose nevirapine regimen for mothers and babies to decrease vertical transmission in sub-Saharan Africa. Lancet 1999;354:803-9. [ Links ]

    42. Sinanovic E, Floyd K, Dudley L, Azevedo V, Grant R, Maher D. Cost and cost-effectiveness of community-based care for tuberculosis in Cape Town, South Africa. Int J Tuberc Lung Dis 2003:9 Suppl 1:S56-62. [ Links ]

    43. Wiktor SZ, Sassan-Morokro M, Grant AD, Abouya L, Karon JM, Maurice C, et al. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial. Lancet 1999;353:1469-75. [ Links ]

    44. Anglaret X, Chene G, Attia A, Toure S, Lafont S, Combe P, et al. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Lancet 1999;353:1463-8. [ Links ]

    45. Badri M, Ehrlich R, Wood R, Maartens G. Initiating cotrimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO/UNAIDS recommendations. AIDS 2001;15:1143-8. [ Links ]

    46. Cleary S, Boulle A, McIntyre D, Coetzee D. Cost-effectiveness of antiretroviral treatment for HIV-positive adults in a South African township. Cape Town: Health Systems Trust; 2003. Available from: http://www.hst.org.za/publications/579. [ Links ]

    47. Richter L, Durrheim K, Giresel D, Solomon V, Van Rooyen H. Evaluation of counselor service provision within the South African context (with specific reference to HIV/AIDS counseling). Pretoria: Department of Health; November 1999. [ Links ]

    48. Coetzee D, Boulle A, Hildebrand K, Asselman V, Van Cutsem G, Goemaere E. Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa. AIDS 2004;18 Suppl 3:S27-S31. [ Links ]

    49. Mosimaneotsile B, Talbot EA, Moeti TL, Hone NM, Moalosi G, Moffat HJ, et al. Value of chest radiography in a tuberculosis prevention programme for HIV-infected people, Botswana. Lancet 2003;362:1551-2. [ Links ]

    50. Department of Health. Operational Plan for comprehensive HIV and AIDS care, management and treatment for South Africa. Pretoria: Department of Health; 2003. [ Links ]